Zeng et al,[9] who conducted a meta-analysis on the association of VDR polymorphisms with the risk of BPH 8 years ago, did not reach definitive conclusions and stated that there were significant limitations. The gene discussed is VDR; the disease is benign prostatic hyperplasia.